Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

466 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Drug therapy of chronic myeloid leukemia].
Hochhaus A, Berger U, Reiter A, Lahaye T, Kreil S, Hehlmann R. Hochhaus A, et al. Among authors: hehlmann r. Med Klin (Munich). 2002 Jan 15;97 Suppl 1:7-15. Med Klin (Munich). 2002. PMID: 11831070 German.
Interferon-alpha, but not the ABL-kinase inhibitor imatinib (STI571), induces expression of myeloblastin and a specific T-cell response in chronic myeloid leukemia.
Burchert A, Wölfl S, Schmidt M, Brendel C, Denecke B, Cai D, Odyvanova L, Lahaye T, Müller MC, Berg T, Gschaidmeier H, Wittig B, Hehlmann R, Hochhaus A, Neubauer A. Burchert A, et al. Among authors: hehlmann r. Blood. 2003 Jan 1;101(1):259-64. doi: 10.1182/blood-2002-02-0659. Epub 2002 Jun 28. Blood. 2003. PMID: 12393722 Free article.
Telomere length in peripheral blood granulocytes reflects response to treatment with imatinib in patients with chronic myeloid leukemia.
Brümmendorf TH, Ersöz I, Hartmann U, Bartolovic K, Balabanov S, Wahl A, Paschka P, Kreil S, Lahaye T, Berger U, Gschaidmeier H, Bokemeyer C, Hehlmann R, Dietz K, Lansdorp PM, Kanz L, Hochhaus A. Brümmendorf TH, et al. Among authors: hehlmann r. Blood. 2003 Jan 1;101(1):375-6. doi: 10.1182/blood-2002-08-2557. Blood. 2003. PMID: 12485943 Free article. No abstract available.
Chronic myeloid leukemia: a model for oncology.
Hehlmann R, Berger U, Hochhaus A. Hehlmann R, et al. Ann Hematol. 2005 Aug;84(8):487-97. doi: 10.1007/s00277-005-1039-z. Epub 2005 Jun 2. Ann Hematol. 2005. PMID: 15931535 Review.
This review deals with some of the recent developments that have evolved since our last review in this journal in 2000 (Hehlmann R, Hochhaus A, Berger U, Reiter A (2000) Current trends in the management of chronic myelogenous leukemia....
This review deals with some of the recent developments that have evolved since our last review in this journal in 2000 (Hehlmann R …
Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet.
Baccarani M, Saglio G, Goldman J, Hochhaus A, Simonsson B, Appelbaum F, Apperley J, Cervantes F, Cortes J, Deininger M, Gratwohl A, Guilhot F, Horowitz M, Hughes T, Kantarjian H, Larson R, Niederwieser D, Silver R, Hehlmann R; European LeukemiaNet. Baccarani M, et al. Among authors: hehlmann r. Blood. 2006 Sep 15;108(6):1809-20. doi: 10.1182/blood-2006-02-005686. Epub 2006 May 18. Blood. 2006. PMID: 16709930 Free article. Review.
Drug treatment is superior to allografting as first-line therapy in chronic myeloid leukemia.
Hehlmann R, Berger U, Pfirrmann M, Heimpel H, Hochhaus A, Hasford J, Kolb HJ, Lahaye T, Maywald O, Reiter A, Hossfeld DK, Huber C, Löffler H, Pralle H, Queisser W, Tobler A, Nerl C, Solenthaler M, Goebeler ME, Griesshammer M, Fischer T, Kremers S, Eimermacher H, Pfreundschuh M, Hirschmann WD, Lechner K, Wassmann B, Falge C, Kirchner HH, Gratwohl A. Hehlmann R, et al. Blood. 2007 Jun 1;109(11):4686-92. doi: 10.1182/blood-2006-11-055186. Epub 2007 Feb 22. Blood. 2007. PMID: 17317858 Free article. Clinical Trial.
Chronic myeloid leukaemia.
Hehlmann R, Hochhaus A, Baccarani M; European LeukemiaNet. Hehlmann R, et al. Lancet. 2007 Jul 28;370(9584):342-50. doi: 10.1016/S0140-6736(07)61165-9. Lancet. 2007. PMID: 17662883 Review.
466 results